Why Do Some Countries Legalize Cannabis? Aren't They Afraid It Will Ruin Families? (Part 3): The Lancet's Harm Matrix, Post-Legalization Backlash, and Thailand's Policy U-Turn

[Global Cannabis Policy Deep-Dive Series]

• (Part 1) The Bankruptcy of the War on Drugs and the Cost of a Runaway Black Market
• (Part 2) Replacing Criminal Punishment with Public Health Regulation: The Logic of Harm Reduction
• (Part 3) The Lancet’s Harm Matrix, Post-Legalization Backlash, and Thailand’s Policy U-Turn (Current Article)
• (Bonus Part) “Alcohol and Tobacco Are Worse—Isn’t Banning Cannabis Unfair?” Deconstructing the Legal and Governance Fallacy

In the first two installments of this series—Part 1: The Bankruptcy of the War on Drugs and Part 2: Replacing Criminal Punishment with Public Health Regulation—we explored how Western governments moved to starve underground cartels, unclog courts, and eliminate fentanyl-laced street weed. Now, in our final installment, we confront the ultimate question head-on:

“Even with public health regulations in place, aren’t governments afraid that cannabis addiction will tear families apart? And what real-world price have countries paid after opening the door?”

To answer this objectively, we must examine both the empirical harm rankings published in leading medical journals and the sobering real-world backlashes experienced across North America and Thailand.

1. “Aren’t They Afraid Families Will Be Ruined?” — The Scientific Benchmark in The Lancet

Western governments and public health agencies are by no means indifferent to addiction or family breakdown. Rather, their legislative debate is anchored in comparative medical assessments of physical toxicity, dependence potential, and social/family harm.

In global addiction medicine, the most widely cited benchmark is the landmark study led by Professor David Nutt (former UK Chief Drug Adviser and Chair of Neuropsychopharmacology at Imperial College London), published in the prestigious medical journal The Lancet. Using a 16-criteria multi-criteria decision analysis, experts evaluated 20 psychoactive substances across “harm to users” (mortality, dependence, mental impairment) and “harm to others” (domestic violence, family breakdown, crime, and economic cost):

This scientific matrix reveals two crucial insights:

1. Alcohol Is the #1 Destroyer of Families: In The Lancet’s composite scoring, alcohol ranked #1 in overall harm—and #1 by a wide margin in “harm to others and families”—because alcohol intoxication directly fuels domestic violence, child abuse, fatal traffic crashes, and liver failure.
2. Where Cannabis Sits: Medically and statistically, cannabis’s dependence potential and social harm sit between or below alcohol and tobacco, and far below heroin, cocaine, and methamphetamine.

Consequently, proponents of regulated legalization argue: If modern societies manage alcohol and tobacco—substances that cause immense family devastation and premature death—through institutional regulation, taxation, and age limits rather than mass incarceration, then cannabis should be placed inside the same regulatory cage, freeing law enforcement to focus 100% on lethal hard drugs like fentanyl, meth, and heroin.

2. Legalization Is No Utopia: Four Severe Real-World Backlashes

However, “less harmful than alcohol” does not mean “harmless.” Once Canada and US states opened legal markets, four serious public health and social challenges quickly surfaced:

1. A Surge in Cannabis-Impaired Driving (DUI)

Unlike alcohol—where a breathalyzer blood-alcohol concentration (such as 0.08%) reliably measures acute impairment—THC is fat-soluble and can remain detectable in blood and body fat for days or weeks after intoxication has worn off. This creates a major forensic headache for traffic police trying to prove acute roadside impairment. Following legalization in Colorado, Washington, and Canada, traffic collisions involving drivers testing positive for THC rose noticeably.

2. Accidental Pediatric Poisonings from Cannabis Edibles

In commercialized US state markets, manufacturers rolled out brightly packaged THC gummy bears, chocolates, and brownies that look nearly identical to everyday candy. When parents fail to lock these products away, young children can consume an entire package at once—leading to severe acute THC toxicity, coma, seizures, and respiratory distress. Pediatric emergency room visits and poison control calls for accidental cannabis ingestion among children under 10 skyrocketed across North America.

3. High-Potency Products and Chronic Psychiatric Strain

Selective breeding and extraction technologies have pushed average THC potency from 3%–4% in the 1980s to 20%–30% in modern flower, and up to 80%–90% in concentrates (shatter, wax, vape oils). Psychiatric studies show that heavy, frequent use of high-potency THC—especially among adolescents and young adults under age 25 whose prefrontal cortex is still developing—significantly elevates the risk of cannabis-induced psychosis, schizophrenia, clinical depression, and “amotivational syndrome” (chronic apathy and loss of academic or career drive), placing a heavy long-term burden on families.

4. The “High-Tax Paradox”: When Legal Weed Is Too Expensive, the Black Market Survives

In California and parts of Canada, governments initially layered 30% to 40% in cumulative excise, state, and local taxes onto legal cannabis, alongside costly compliance rules. With legal dispensary prices nearly double those on the street, price-sensitive heavy users simply returned to illicit dealers—undermining the core goal of wiping out the black market.

3. Asia’s Cautionary Tale: Why Thailand Made a Dramatic Policy U-Turn

If North America and Germany represent structured regulatory experiments, Thailand demonstrated the chaos that erupts when a country decriminalizes cannabis without a regulatory framework in place.

In June 2022, seeking to boost post-pandemic tourism and agricultural income, Thailand removed cannabis from its narcotics list—becoming the first country in Asia to decriminalize the plant. However, due to parliamentary gridlock, the comprehensive Cannabis Control Act meant to regulate age limits, THC potency, and licensing stalled, plunging Thailand into a two-year regulatory vacuum:

• Runaway Street Commercialization: Tens of thousands of unlicensed dispensaries, neon-lit weed trucks, and cannabis cafes sprang up overnight across Bangkok, Phuket, and Chiang Mai, right next to schools and temples.
• Youth Exposure and Medical Backlash: Without strict retail enforcement, underage consumption and tourist hospital admissions surged several-fold, sparking fierce backlash from Thai parents, physicians, and civic groups.
• The Policy Reversal: Confronted with mounting social costs, the Thai government slammed on the brakes—moving to restrict cannabis back to strictly medical and health purposes and cracking down on unlicensed recreational street shops.

Thailand’s experience proved to the world that lifting prohibition without first building an airtight legal and public health cage invites immediate social disorder.

Series Conclusion: A “Lesser of Two Evils” Experiment with No Easy Answers

Stepping back across all three parts of our series, we can distill the global cannabis debate into three core takeaways:

1. Legalization Is a Forced Harm-Reduction Strategy: Western nations did not legalize cannabis because they think it is harmless or because they don’t care about families. They did so because tens of millions of citizens were already using it, and the “War on Drugs” had gone bankrupt—handing billions to violent cartels, clogging courts, and destroying working families through lifelong criminal records.
2. Replacing the Black-Market Jungle with a Public Health Cage: By regulating cannabis like alcohol and tobacco, governments seek to eliminate lethal fentanyl adulteration, enforce strict age checks, and convert underground profits into tax revenues for addiction treatment.
3. The Costs Remain Real and Fiercely Debated: Rising impaired driving, pediatric edible poisonings, psychiatric risks from high-potency THC, and Thailand’s chaotic U-turn prove that legalization is no silver bullet.

Ultimately, cannabis legalization in the West is a grand “lesser of two evils” policy experiment—an attempt to use transparency, taxation, and public health medicine to tame an underground market that criminal law could no longer control. For societies in Asia where illicit cannabis prevalence remains low, understanding both why Western prohibition collapsed and what painful side effects followed legalization offers an indispensable lens for crafting rational, evidence-based drug policies.

Complete Series Index

• Part 1: Why Do Some Countries Legalize Cannabis? (Part 1): The Bankruptcy of the War on Drugs and the Cost of a Runaway Black Market
• Part 2: Why Do Some Countries Legalize Cannabis? (Part 2): Replacing Criminal Punishment with Public Health Regulation
• Part 3: Why Do Some Countries Legalize Cannabis? (Part 3): The Lancet’s Harm Matrix, Post-Legalization Backlash, and Thailand’s Policy U-Turn (Current Article)